Literature DB >> 10373612

Antiviral Activities of Marine Pseudomonas Polysaccharides and Their Oversulfated Derivatives.

.   

Abstract

: A marine Pseudomonas species WAK-1 strain simultaneously produces extracellular glycosaminoglycan and sulfated polysaccharide. Among the antiviral activities tested for these polysaccharides, the latter showed anti-HSV-1 activity in RPMI 8226 cells (50% effective concentration is 1.4 µg/ml). Oversulfated derivatives of these polysaccharides prepared by dicyclohexylcarbodiimide-mediated reaction for both polysaccharides showed antiviral activities against influenza virus type A (for glycosaminoglycan, 50% effective concentration is 11.0 µg/ml; for another, 2.9 µg/ml). Glycosaminoglycan, sulfated polysaccharide, and their chemically synthesized oversulfated derivatives did not show antiviral activities against influenza virus type B and human immunodeficiency virus type 1. No cytotoxicity of these products was noted against host cells at the 50% cytotoxic concentration of 100 µg/ml, except that naturally occurring sulfated polysaccharide had 50% cytotoxicity against MT-4 cells at 8-21 µg/ml.

Entities:  

Year:  1999        PMID: 10373612     DOI: 10.1007/pl00011753

Source DB:  PubMed          Journal:  Mar Biotechnol (NY)        ISSN: 1436-2228            Impact factor:   3.619


  9 in total

1.  Characterization of exopolysaccharides produced by cyanobacteria isolated from Polynesian microbial mats.

Authors:  Laurent Richert; Stjepko Golubic; Roland Le Guédès; Jacqueline Ratiskol; Claude Payri; Jean Guezennec
Journal:  Curr Microbiol       Date:  2005-10-25       Impact factor: 2.188

Review 2.  Bioactive substances produced by marine isolates of Pseudomonas.

Authors:  Alim Isnansetyo; Yuto Kamei
Journal:  J Ind Microbiol Biotechnol       Date:  2009-07-07       Impact factor: 3.346

Review 3.  Present and future medical applications of microbial exopolysaccharides.

Authors:  Misu Moscovici
Journal:  Front Microbiol       Date:  2015-09-29       Impact factor: 5.640

4.  Advances in Antiviral Material Development.

Authors:  Lili Liang; Ashiq Ahamed; Liya Ge; Xiaoxu Fu; Grzegorz Lisak
Journal:  Chempluschem       Date:  2020-08-21       Impact factor: 3.210

5.  Isolation, Optimization of Fermentation Conditions, and Characterization of an Exopolysaccharide from Pseudoalteromonas agarivorans Hao 2018.

Authors:  Lujiang Hao; Wenlin Liu; Kai Liu; Kai Shan; Chunlei Wang; Chenxiang Xi; Jianbang Liu; Qiuping Fan; Xiaofei Zhang; Xiaoping Lu; Yanrui Xu; RuiWen Cao; Yaohong Ma; Lan Zheng; Bo Cui
Journal:  Mar Drugs       Date:  2019-12-13       Impact factor: 5.118

Review 6.  Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19).

Authors:  Monic Andrew; Gurunathan Jayaraman
Journal:  Carbohydr Res       Date:  2021-05-03       Impact factor: 2.975

Review 7.  The Antiviral Activity of Bacterial, Fungal, and Algal Polysaccharides as Bioactive Ingredients: Potential Uses for Enhancing Immune Systems and Preventing Viruses.

Authors:  Worraprat Chaisuwan; Yuthana Phimolsiripol; Thanongsak Chaiyaso; Charin Techapun; Noppol Leksawasdi; Kittisak Jantanasakulwong; Pornchai Rachtanapun; Sutee Wangtueai; Sarana Rose Sommano; SangGuan You; Joe M Regenstein; Francisco J Barba; Phisit Seesuriyachan
Journal:  Front Nutr       Date:  2021-11-05

Review 8.  Extracellular Polymeric Substances: Still Promising Antivirals.

Authors:  Raquel Bello-Morales; Sabina Andreu; Vicente Ruiz-Carpio; Inés Ripa; José Antonio López-Guerrero
Journal:  Viruses       Date:  2022-06-19       Impact factor: 5.818

Review 9.  Role of Bacterial Exopolysaccharides as Agents in Counteracting Immune Disorders Induced by Herpes Virus.

Authors:  Concetta Gugliandolo; Antonio Spanò; Teresa L Maugeri; Annarita Poli; Adriana Arena; Barbara Nicolaus
Journal:  Microorganisms       Date:  2015-08-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.